UnitedHealth Group (UNH) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

UNH Stock Forecast


UnitedHealth Group stock forecast is as follows: an average price target of $569.20 (represents a -4.23% downside from UNH’s last price of $594.32) and a rating consensus of 'Buy', based on 28 wall street analysts offering a 1-year stock forecast.

UNH Price Target


The average price target for UnitedHealth Group (UNH) is $569.20 based on 1-year price targets from 28 Wall Street analysts in the past 3 months, with a price target range of $647.00 to $442.00. This represents a potential -4.23% downside from UNH's last price of $594.32.

UNH Analyst Ratings


Buy

According to 28 Wall Street analysts, UnitedHealth Group's rating consensus is 'Buy'. The analyst rating breakdown for UNH stock is 1 'Strong Buy' (3.57%), 23 'Buy' (82.14%), 2 'Hold' (7.14%), 2 'Sell' (7.14%), and 0 'Strong Sell' (0.00%).

UnitedHealth Group Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 17, 2024David ToungArgus Research$600.00$565.786.05%0.96%
Jul 17, 2024David MacDonaldTruist Financial$640.00$548.8716.60%7.69%
Jul 17, 2024Scott FidelStephens$600.00$548.879.32%0.96%
Jul 17, 2024David WindleyJefferies$647.00$573.2812.86%8.86%
Jun 05, 2024Sidharth SahooHSBC$580.00$503.1215.28%-2.41%
Apr 19, 2024George HillDeutsche Bank$562.00$493.1813.95%-5.44%
Apr 17, 2024Stephen BaxterWells Fargo$525.00$483.158.66%-11.66%
Apr 17, 2024Ben HendrixRBC Capital$555.00$468.8918.36%-6.62%
Apr 17, 2024Jessica TassanPiper Sandler$571.00$468.8921.78%-3.92%
Apr 11, 2024Jessica TassanPiper Sandler$566.00$450.0525.76%-4.77%
Row per page
Go to

The latest UnitedHealth Group stock forecast, released on Jul 17, 2024 by David Toung from Argus Research, set a price target of $600.00, which represents a 6.05% increase from the stock price at the time of the forecast ($565.78), and a 0.96% increase from UNH last price ($594.32).

UnitedHealth Group Price Target by Period


1M3M12M
# Anlaysts-412
Avg Price Target-$621.75$574.17
Last Closing Price$594.32$594.32$594.32
Upside/Downside-100.00%4.62%-3.39%

In the current month, the average price target of UnitedHealth Group stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to UnitedHealth Group's last price of $594.32. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Sep 10, 2024Wells FargoBuyBuyHold
Sep 10, 2024UBSUnderperformUnderperformHold
Aug 19, 2024Wells FargoBuyBuyHold
Jul 17, 2024Wells FargoBuyBuyHold
Jul 17, 2024RBC CapitalUnderperformUnderperformHold
Jul 17, 2024RBC CapitalOutperformOutperformHold
Jul 17, 2024Cowen & Co.BuyBuyHold
Jul 17, 2024Morgan StanleyOverweightOverweightHold
Jul 17, 2024Wells FargoOverweightOverweightHold
Jul 17, 2024StephensOverweightOverweightHold
Row per page
Go to

UnitedHealth Group's last stock rating was published by Wells Fargo on Sep 10, 2024. The company gave UNH a "Buy" rating, the same as its previous rate.

UnitedHealth Group Financial Forecast


UnitedHealth Group Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jul 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue-------------$92.36B$91.79B$91.13B$81.93B$80.38B-$79.78B$72.93B$71.83B$70.77B$69.74B$65.02B$64.76B$61.80B$64.06B$60.47B$59.88B
Avg Forecast$116.81B$114.14B$114.47B$113.53B$109.32B$107.35B$107.33B$106.61B$100.91B$99.15B$98.79B$99.23B$92.13B$91.41B$90.97B$89.71B$82.48B$80.52B$79.68B$78.73B$72.98B$71.38B$69.51B$69.07B$64.96B$63.79B$63.48B$64.16B$60.96B$59.76B
High Forecast$118.67B$115.95B$116.29B$115.33B$111.06B$109.06B$109.04B$108.31B$102.52B$100.31B$100.36B$100.81B$93.44B$92.87B$92.42B$91.14B$83.80B$81.80B$79.68B$79.57B$73.77B$72.15B$70.25B$69.81B$65.66B$64.47B$64.16B$64.85B$61.61B$60.40B
Low Forecast$115.71B$113.06B$113.38B$112.45B$108.29B$106.33B$106.32B$105.61B$99.96B$97.74B$97.85B$98.30B$90.78B$90.55B$90.11B$88.86B$81.70B$79.76B$79.68B$77.47B$71.81B$70.24B$68.39B$67.97B$63.92B$62.77B$62.47B$63.14B$59.98B$58.81B
# Analysts661211109878136612999555666661110101165
Surprise %-------------1.01%1.01%1.02%0.99%1.00%-1.01%1.00%1.01%1.02%1.01%1.00%1.02%0.97%1.00%0.99%1.00%

UnitedHealth Group's average Quarter revenue forecast for Dec 23 based on 12 analysts is $92.13B, with a low forecast of $90.78B, and a high forecast of $93.44B. UNH's average Quarter revenue forecast represents a -0.25% decrease compared to the company's last Quarter revenue of $92.36B (Sep 23).

UnitedHealth Group EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jul 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts661211109878136612999555666661110101165
EBITDA-------------$9.53B$7.96B$8.26B$7.02B$7.78B-$7.37B$6.19B$6.40B$6.65B$7.38B$4.11B$5.29B$9.90B$5.64B$5.69B$5.63B
Avg Forecast$10.57B$10.33B$10.36B$10.28B$9.90B$9.72B$9.72B$9.65B$9.13B$8.97B$8.94B$9.03B$8.34B$8.27B$8.23B$8.21B$7.47B$6.87B$7.26B$7.46B$5.93B$6.24B$6.21B$5.81B$3.92B$4.57B$6.45B$5.50B$5.49B$5.44B
High Forecast$10.74B$10.50B$10.53B$10.44B$10.05B$9.87B$9.87B$9.80B$9.28B$9.08B$9.08B$10.83B$8.46B$8.41B$8.37B$9.85B$7.59B$8.24B$7.26B$8.95B$7.12B$7.49B$7.46B$6.98B$4.71B$5.48B$7.74B$6.60B$6.59B$6.52B
Low Forecast$10.47B$10.23B$10.26B$10.18B$9.80B$9.63B$9.62B$9.56B$9.05B$8.85B$8.86B$7.22B$8.22B$8.20B$8.16B$6.57B$7.40B$5.49B$7.26B$5.97B$4.75B$4.99B$4.97B$4.65B$3.14B$3.65B$5.16B$4.40B$4.39B$4.35B
Surprise %-------------1.15%0.97%1.01%0.94%1.13%-0.99%1.04%1.03%1.07%1.27%1.05%1.16%1.53%1.03%1.04%1.04%

12 analysts predict UNH's average Quarter EBITDA for Dec 23 to be $8.34B, with a high of $8.46B and a low of $8.22B. This is -12.52% lower than UnitedHealth Group's previous annual EBITDA (Sep 23) of $9.53B.

UnitedHealth Group Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jul 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts661211109878136612999555666661110101165
Net Income-------------$5.84B$5.47B$5.61B$4.76B$5.26B-$5.03B$4.19B$4.09B$4.27B$4.86B$2.21B$3.17B$6.64B$3.38B$3.54B$3.54B
Avg Forecast$8.10B$8.47B$8.02B$8.04B$7.25B$7.50B$7.11B$7.04B$6.41B$6.55B$6.17B$5.96B$5.55B$5.88B$5.56B$5.42B$4.80B$4.38B$4.80B$4.92B$3.90B$3.98B$3.99B$3.83B$2.11B$2.74B$4.32B$3.30B$3.42B$3.42B
High Forecast$8.26B$8.64B$8.18B$8.21B$7.40B$7.65B$7.26B$7.18B$6.54B$6.73B$6.30B$7.15B$5.59B$6.00B$5.67B$6.50B$4.90B$5.26B$4.80B$5.91B$4.68B$4.78B$4.78B$4.60B$2.53B$3.29B$5.19B$3.96B$4.10B$4.10B
Low Forecast$8.00B$8.36B$7.92B$7.94B$7.16B$7.40B$7.02B$6.95B$6.33B$6.39B$6.09B$4.77B$5.48B$5.81B$5.49B$4.33B$4.74B$3.51B$4.80B$3.94B$3.12B$3.19B$3.19B$3.06B$1.69B$2.19B$3.46B$2.64B$2.74B$2.73B
Surprise %-------------0.99%0.98%1.04%0.99%1.20%-1.02%1.07%1.03%1.07%1.27%1.05%1.16%1.53%1.03%1.04%1.04%

UnitedHealth Group's average Quarter net income forecast for Dec 23 is $5.55B, with a range of $5.48B to $5.59B. UNH's average Quarter net income forecast represents a -4.92% decrease compared to the company's last Quarter net income of $5.84B (Sep 23).

UnitedHealth Group SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jul 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts661211109878136612999555666661110101165
SG&A------------------------------
Avg Forecast$17.63B$17.23B$17.28B$17.14B$16.50B$16.20B$16.20B$16.09B$15.23B$14.96B$14.91B$14.98B$13.91B$13.80B$13.73B$13.54B$12.45B$12.15B$12.02B$9.56B$8.86B$8.67B$8.44B$8.39B$7.89B$7.75B$7.71B$7.79B$7.40B$7.26B
High Forecast$17.91B$17.50B$17.55B$17.41B$16.76B$16.46B$16.46B$16.35B$15.47B$15.14B$15.15B$15.22B$14.10B$14.02B$13.95B$13.76B$12.65B$12.35B$12.02B$9.66B$8.96B$8.76B$8.53B$8.48B$7.97B$7.83B$7.79B$7.88B$7.48B$7.34B
Low Forecast$17.47B$17.06B$17.11B$16.97B$16.35B$16.05B$16.05B$15.94B$15.09B$14.75B$14.77B$14.84B$13.70B$13.67B$13.60B$13.41B$12.33B$12.04B$12.02B$9.41B$8.72B$8.53B$8.31B$8.25B$7.76B$7.62B$7.59B$7.67B$7.28B$7.14B
Surprise %------------------------------

UnitedHealth Group's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to UNH last annual SG&A of $NaN (undefined).

UnitedHealth Group EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jul 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts661211109878136612999555666661110101165
EPS-------------$6.31$5.88$6.01$5.10$5.63-$5.34$4.45$4.34$4.52$5.15$2.34$3.34$6.99$3.57$3.74$3.74
Avg Forecast$8.72$9.12$8.64$8.66$7.81$8.08$7.66$7.58$6.91$7.06$6.65$6.61$5.98$6.33$5.99$6.16$5.17$5.43$5.21$5.37$4.31$4.42$4.43$4.39$2.41$3.11$5.28$3.63$3.78$3.75
High Forecast$8.90$9.31$8.82$8.84$7.97$8.25$7.82$7.74$7.05$7.26$6.79$6.75$6.02$6.47$6.11$6.29$5.28$5.54$5.21$5.45$4.37$4.48$4.49$4.45$2.44$3.15$5.35$3.68$3.83$3.80
Low Forecast$8.62$9.01$8.53$8.56$7.72$7.98$7.57$7.49$6.82$6.89$6.57$6.53$5.90$6.26$5.92$6.09$5.11$5.36$5.21$5.26$4.22$4.32$4.34$4.30$2.36$3.04$5.17$3.55$3.70$3.67
Surprise %-------------1.00%0.98%0.98%0.99%1.04%-0.99%1.03%0.98%1.02%1.17%0.97%1.08%1.32%0.98%0.99%1.00%

According to 12 Wall Street analysts, UnitedHealth Group's projected average Quarter EPS for Dec 23 is $5.98, with a low estimate of $5.90 and a high estimate of $6.02. This represents a -5.16% decrease compared to UNH previous annual EPS of $6.31 (Sep 23).

UnitedHealth Group Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
CVSCVS Health$57.98$103.7778.98%Hold
HUMHumana$321.56$500.8455.75%Hold
CNCCentene$75.35$92.6022.89%Buy
ELVElevance Health$550.84$556.911.10%Buy
MOHMolina Healthcare$358.20$358.630.12%Hold
UNHUnitedHealth Group$594.32$569.20-4.23%Buy
CICigna$364.72$318.74-12.61%Buy
ALHCAlignment Healthcare$11.89$9.50-20.10%Buy

UNH Forecast FAQ


Yes, according to 28 Wall Street analysts, UnitedHealth Group (UNH) is considered a 'Buy'. The rating consensus is based on 1 'Strong Buy' and 23 'Buy' recommendations, accounting for 85.71% of UNH's total ratings.

UnitedHealth Group (UNH) average price target is $569.2 with a range of $442 to $647, implying a -4.23% from its last price of $594.32. The data is based on 28 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

According to Wall Street analysts' prediction for UNH stock, the company can go down by -4.23% (from the last price of $594.32 to the average price target of $569.2), up by 8.86% based on the highest stock price target, and down by -25.63% based on the lowest stock price target.

UNH's average twelve months analyst stock price target of $569.2 does not support the claim that UnitedHealth Group can reach $900 in the near future.

UnitedHealth Group's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $430.62B (high $437.47B, low $426.55B), average EBITDA is $38.98B (high $39.6B, low $38.61B), average net income is $28.9B (high $29.49B, low $28.54B), average SG&A $65B (high $66.03B, low $64.38B), and average EPS is $31.14 (high $31.78, low $30.76). UNH's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $458.94B (high $466.25B, low $454.61B), average EBITDA is $41.54B (high $42.2B, low $41.15B), average net income is $32.62B (high $33.3B, low $32.22B), average SG&A $69.27B (high $70.37B, low $68.62B), and average EPS is $35.15 (high $35.88, low $34.72).

Based on UnitedHealth Group's last annual report (Dec 2022), the company's revenue was $322.13B, beating the average analysts forecast of $321.41B by 0.22%. Apple's EBITDA was $29.8B, beating the average prediction of $29.05B by 2.58%. The company's net income was $20.12B, beating the average estimation of $18.91B by 6.42%. Apple's SG&A was $0, missing the average forecast of $46.18B by -100.00%. Lastly, the company's EPS was $21.47, beating the average prediction of $21.18 by 1.37%. In terms of the last quarterly report (Sep 2023), UnitedHealth Group's revenue was $92.36B, beating the average analysts' forecast of $91.41B by 1.04%. The company's EBITDA was $9.53B, beating the average prediction of $8.27B by 15.20%. UnitedHealth Group's net income was $5.84B, missing the average estimation of $5.88B by -0.63%. The company's SG&A was $0, missing the average forecast of $13.8B by -100.00%. Lastly, the company's EPS was $6.31, missing the average prediction of $6.33 by -0.38%